Regulation of human bone marrow-derived osteoprogenitor cells by osteogenic growth factors.
Open Access
- 1 February 1995
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 95 (2) , 881-887
- https://doi.org/10.1172/jci117738
Abstract
Human bone marrow contains a distinct cell population that expresses bone proteins and responds to transforming growth factor beta 1 (TGF-beta), but not to hematopoietic growth factors (Long, M. W., J. L. Williams, and K. G. Mann. 1990. J. Clin. Invest. 86:1387-1395). We now report the isolation, characterization, and growth factor responsiveness of these precursors to human osteoblasts and the identification of a human osteoprogenitor cell. Immunological separation of human bone marrow nonadherent low-density (NALD) cells results in a marked enrichment of cells that express osteocalcin, osteonectin, and bone alkaline phosphatase. Flow cytometric analyses show that distinct cell subpopulations exist among these isolated cells. The majority of the bone antigen-positive cells are approximately the size of a lymphocyte, whereas other, less frequent antibody-separated subpopulations consist of osteoblast-like cells and osteoprogenitor cells. In serum-free cultures, TGF-beta stimulates the small, antigen-positive cells to become osteoblast-like, as these cells both increase in size, and express increased levels of osteocalcin and alkaline phosphatase. Antibody-separated cells also contain a separate population of clonal progenitor cells that form colonies of osteoblast-like cells when cultured in serum-free, semi-solid media. Two types of human osteoprogenitor cells are observed: a colony-forming cell (CFC) that generates several hundred bone antigen-positive cells, and a more mature cluster-forming cell that has a lesser proliferative potential and thus generates clusters of 20-50 antigen-positive cells. Osteopoietic colony-forming cells and cluster-forming cells have an obligate but differential requirement for osteogenic growth factors. The CFCs respond to TGF-beta, basic fibroblast growth factor (bFGF), bone morphogenic protein-2 (BMP-2), and 1, 25-dihydroxy vitamin D3 (1,25-OH D3). In contrast to the colony-forming cells, cluster-forming cells are regulated predominantly by 1,25-OH D3 and TGF-beta, but fail to respond to bFGF. We conclude that human bone marrow contains a nonhematogenous, heterogeneous population of bone precursor cells among which exists a population of proliferating osteoprogenitor cells. Further characterization of these bone precursor cell populations should yield important information on their role in osteogenesis in both health and disease.Keywords
This publication has 34 references indexed in Scilit:
- Concepts of Osteoblast Growth and Differentiation: Basis for Modulation of Bone Cell Development and Tissue FormationCritical Reviews in Oral Biology & Medicine, 1992
- Blood cell cytoadhesion molecules.1992
- Expression of human bone-related proteins in the hematopoietic microenvironment.Journal of Clinical Investigation, 1990
- CYTOKINE REGULATION OF THE HUMAN BURST-FORMING UNIT-MEGAKARYOCYTE1990
- OPPOSING EFFECTS OF FIBROBLAST GROWTH-FACTOR AND PERTUSSIS TOXIN ON ALKALINE-PHOSPHATASE, OSTEOPONTIN, OSTEOCALCIN, AND TYPE-I COLLAGEN MESSENGER-RNA LEVELS IN ROS 17/2.8-CELLS1989
- Fibroblast growth factor enhances type beta 1 transforming growth factor gene expression in osteoblast-like cells.The Journal of cell biology, 1989
- Identification of a vitamin D-responsive protein on the surface of human osteosarcoma cells.Proceedings of the National Academy of Sciences, 1989
- The molecular control of cell division, differentiation commitment and maturation in haemopoietic cellsNature, 1989
- Synergistic regulation of human megakaryocyte development.Journal of Clinical Investigation, 1988
- Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridizationThe Journal of cell biology, 1988